GSK has handed over $45 million upfront to fellow London-based firm Relation to help the pharma identify new targets for ...

GSK plc stock is downgraded due to litigation risks, weak sales, and market pressures, dividend yield remains a bright spot. Click for more on GSK stock.

A Task Force has been convened by local MP, Michelle Scrogham, to look at the support provided to staff, local suppliers, and the local ...

Dec 9 (Reuters) - British drugmaker GSK (GSK.L), opens new tab said on Monday its experimental cancer drug Blenrep in combination with other treatments reduced the risk of death by 42% in multiple ...

GSK featured in my "Top 10" pharma social media ... He likens the company's history with social media to learning to ride a bicycle, and says while it is important to understand the opportunities ...

TD Cowen analyst Steve Scala maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of $45.00. The ...

GSK GSK stock has declined 20.2% in the past three months compared with a decrease of 12.3% for the industry. The stock has also underperformed the sector and the S&P 500 index, as seen in the ...

GSK's former head of vaccines R&D – Dr Emmanuel ... The London-based company was founded by venture capital firm Medicxi in 2019, but has now come out of stealth mode with financial backing ...